
Medscheme secures Sisonke administration mandate
The appointment strengthens Medscheme’s foothold in the employer-based healthcare sector.

The appointment strengthens Medscheme’s foothold in the employer-based healthcare sector.

After concluding its section 43 inquiry into Bonitas, the CMS has determined that the allegations merit a further forensic investigation.

The outcome of Discovery Health’s appeal before the SCA will affect the outcome of the member’s claim for R1.4 million.

Medical inflation outpaces CPI because of unique pressures such as the rising costs of technology, chronic diseases, and private healthcare pricing.

The medical scheme says it will use its reserves to limit contribution increases, while possibly improving members’ benefits and reducing co-payments.